The Cost Of Fear
A recent study found that more than half of millennial women have money to invest but, out of fear, are not doing so. Here’s the… Read More »The Cost Of Fear
A recent study found that more than half of millennial women have money to invest but, out of fear, are not doing so. Here’s the… Read More »The Cost Of Fear
With healthcare ETFs displaying positive momentum (and a plethora of reasons to believe that this momentum will continue), this triple-leveraged healthcare ETF could be an… Read More »A Triple Dose Of Healthcare Momentum
A dead money stock is one going nowhere (up or down) in the short-term. With this trading strategy, however, you can generate a sizable return… Read More »Get A Healthy Return From A Dead Money Stock
It’s not buy-and-hold investing. And it’s not day trading (but it may be a good way to ease into it). Here’s a primer on swing… Read More »Get A Handle On Swing Trading
This under-the-radar cannabis company is taking a different approach from most – choosing to be the big fish in small ponds. Here’s why its strategy… Read More »An “Unassuming” Cannabis Company With A “Big Fish” Strategy
Small-cap stocks have been one of the hottest trades of the year. Here’s how the managers of two outperforming small-cap funds select their stocks –… Read More »Cracking The Small-Cap Code
Do companies led by women outperform the market? Here’s what a pair of researchers found when they examined the data – and the most important… Read More »The Facts About Female-Led Firms
Among small-cap stocks – which have been robustly outperforming their large-cap counterparts this year – healthcare small-caps have been the most impressive performers. Which healthcare… Read More »Bargain Hunting In Declining Health
They’re the other side of socially responsible investments: sin stocks. Here’s why cannabis, gambling, alcohol and tobacco stocks (among others) can make sense to own… Read More »Socially Irresponsible Investing
As the second-quarter earnings season gets underway, these three healthcare stocks – including a biotech that now has a near monopoly on the cystic fibrosis… Read More »Tip Top Healthcare Bets From Top Analysts